AstraZeneca's AKT inhibitor Truqap hits main goal of prostate cancer study
FirstWord Pharma - 25 Nov 2024AstraZeneca's AKT inhibitor Truqap hits main goal of prostate cancer study ...
astrazeneca
AstraZeneca's AKT inhibitor Truqap hits main goal of prostate cancer study ...
AZ's Truqap delivers phase 3 win in prostate cancer subtype after recent breast cancer miss
FiercePharma - 25 Nov 2024AZ's Truqap delivers phase 3 win in prostate cancer subtype after recent breast cancer miss ...
AstraZeneca PLC (NASDAQ:AZN) Focuses on Growth in the U.S.: Is It the Best Time to Invest In AZN?
Yahoo Finance - 25 Nov 2024AstraZeneca PLC (NASDAQ:AZN) Focuses on Growth in the U.S.: Is It the Best Time to Invest In AZN? ...
Positive CAPItello-281 Phase III trial for AstraZeneca
The Pharma Letter - 25 Nov 2024Positive CAPItello-281 Phase III trial for AstraZeneca ...
GCAR and AstraZeneca execute agreement to evaluate AZD1390 for glioblastoma
Clinical Trials Arena - 25 Nov 2024GCAR and AstraZeneca execute agreement to evaluate AZD1390 for glioblastoma ...
AstraZeneca Names A MSK Leader To Global Cancer Post
Forbes - 25 Nov 2024AstraZeneca Names A MSK Leader To Global Cancer Post ...
10 Most Promising Cancer Stocks According to Hedge Funds
Insider Monkey - 22 Nov 202410 Most Promising Cancer Stocks According to Hedge Funds ...
AstraZeneca announces results from CAPItello-281 trial
TipRanks - 25 Nov 2024AstraZeneca announces results from CAPItello-281 trial ...
AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments
Reuters.com - 12 Nov 2024AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments ...
China has trapped the tiger of AstraZeneca’s growth
Financial Times - 13 Nov 2024China has trapped the tiger of AstraZeneca’s growth ...
Transforming kidney health and the burden of CKD
AstraZeneca - 21 Nov 2024Transforming kidney health and the burden of CKD ...
AstraZeneca’s Truqap Hits In Prostate Cancer
Citeline News & Insights - 25 Nov 2024AstraZeneca’s Truqap Hits In Prostate Cancer ...
AstraZeneca cans phase 2 opioid use disorder drug over interaction with common antifungal med
Fierce Biotech - 22 Nov 2024AstraZeneca cans phase 2 opioid use disorder drug over interaction with common antifungal med ...
AstraZeneca Fends Off Adcomm’s Safety Concerns on Andexxa, Axes Mid-Stage Opioid Use Disorder Drug
BioSpace - 22 Nov 2024AstraZeneca Fends Off Adcomm’s Safety Concerns on Andexxa, Axes Mid-Stage Opioid Use Disorder Drug ...
AIM ImmunoTech Defends Board Against $8M Activist Demand Amid AstraZeneca Partnership | AIM Stock News
StockTitan - 25 Nov 2024AIM ImmunoTech Defends Board Against $8M Activist Demand Amid AstraZeneca Partnership | AIM Stock News ...
AstraZeneca (AZN): A Top Pick for Hedge Funds Due to Innovation and Rising Demand
Yahoo Finance - 23 Nov 2024AstraZeneca (AZN): A Top Pick for Hedge Funds Due to Innovation and Rising Demand ...
AstraZeneca PLC (NASDAQ:AZN) Focuses on Growth in the U.S.: Is It the Best Time to Invest In AZN?
Insider Monkey - 25 Nov 2024AstraZeneca PLC (NASDAQ:AZN) Focuses on Growth in the U.S.: Is It the Best Time to Invest In AZN? ...
AstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the US
Business Wire - 20 Nov 2024AstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the US ...
African Cluster
AstraZeneca - 25 Oct 2024African Cluster ...